Table of contents

Extended reports

• Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients (14 May, 2007)

  E Reefman, H Kuiper, P C Limburg, C G M Kallenberg, M Bijl
• Knee osteoarthritis. Efficacy of a new method of contrast-enhanced musculoskeletal ultrasonography in detection of synovitis in patients with knee osteoarthritis in comparison with magnetic resonance imaging (14 May, 2007)

  I H Song, G R Burmester, M Backhaus, C E Althoff, K G Hermann, A K Scheel, C Werner, T Knetsch, M Schoenharting
• Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case–control study (24 August, 2007) Free

  P Gisondi, I Tinazzi, G El-Dalati, M Gallo, D Biasi, L M Barbara, G Girolomoni
• Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis (31 January, 2007)

  P de Groote, V Gressin, E Hachulla, P Carpentier, L Guillevin, A Kahan, J Cabane, C Francès, N Lamblin, E Diot, F Patat, J Sibilia, H Petit, J-L Cracowski, P Clerson, M Humbert, for the ItinerAIR-Scleroderma Investigators
• Changing pattern in the prescription of biological treatment in rheumatoid arthritis. A 7-year follow-up of 1839 patients in southern Sweden (14 May, 2007)

  M K Söderlin, P Geborek
• The association of bone attrition with knee pain and other MRI features of osteoarthritis (14 May, 2007)

  G Hernández-Molina, T Neogi, D J Hunter, J Niu, A Guermazi, S Reichenbach, F W Roemer, C E McLennan, D T Felson
• Magnetic resonance imaging and bone scintigraphy in the differential diagnosis of unclassified arthritis (8 February, 2007)

  A Duer, M Østergaard, K Hørslev-Petersen, J Vallø
• Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E₂

  (7 May, 2007)

  S C Mastbergen, J W J Bijlsma, F P J G Lafeber
• Survival and causes of death in 366 Hungarian patients with systemic sclerosis (22 May, 2007)

  L Czirják, G Kumánovics, C Varjú, Z Nagy, A Pákozdi, Z Szekanecz, G Szűcs
• Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? (21 May, 2007)

  A Gonzalez, H Maradit Kremers, C S Crowson, K V Ballman, V L Roger, S J Jacobsen, W M O’Fallon, S E Gabriel
• Cigarette smoking significantly increases basal metabolic rate in patients with rheumatoid arthritis (14 May, 2007)

  G S Metsios, A Stavropoulos-Kalinoglou, A M Nevill, K M J Douglas, Y Koutedakis, G D Kitas
• The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case–cohort study (1 June, 2007)

  S Bernatsky, L Joseph, J-F Boivin, C Gordon, M Urowitz, D Gladman, P R Fortin, E Ginzler, S-C Bae, S Barr, S Edworthy, D Isenberg, A Rahman, M Petri, G S Alarcón, C Aranow, M-A Dooley, R Rajan, J-L Sénécal, M Zummer, S Manzi, R Ramsey-Goldman, A E Clarke
• Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia (25 May, 2007)

  M Fabris, L Quartuccio, S Salvin, G Pozzato, V De Re, C Mazzaro, C Ferri, C Baldini, S De Vita
• Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon γ assay

  (20 July, 2007)

  G Matulis, P Jüni, P M Villiger, S D Gadola
• Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial (1 June, 2007)

  A Hartkamp, R Geenen, G L R Godaert, H Bootsma, A A Kruize, J W J Bijlsma, R H W M Derksen
• Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis (25 May, 2007)

  M C Vonk, Z Marjanovic, F H J van den Hoogen, S Zohar, A V M B Schattenberg, W E Fibbe, J Larghero, E Gluckman, F W M B Preijers, A P J van Dijk, J J Bax, P Roblot, P L C M van Riel, J M van Laar, D Farge
• Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis? (29 June, 2007)

  M T Carulli, C Handler, J G Coghlan, C M Black, C P Denton
• Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients (8 June, 2007)

  L Teixeira, L Mouthon, A Mahr, A Berezné, C Agard, M Mehrenberger, L-H Noël, P Trolliet, C Frances, J Cabane, L Guillevin